General Information of the Protein
Protein ID
PT06144
Protein Name
Proto-oncogene tyrosine-protein kinase Src
Secondarily
Protein Name
Proto-oncogene c-Src
pp60c-src
Gene Name
SRC
Sequence
MGSNKSKPKDASQRRRSLEPAENVHGAGGAFPASQTPSKPASADGHRGPNAAFVPPAAAEPKLFGGFNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL
    Show/Hide
Organism
Rattus norvegicus, Rat
Protein Classification
Enzyme
>
Kinase
>
Protein Kinase
>
TK protein kinase group
>
Tyrosine protein kinase Src family
Function
Non-receptor protein tyrosine kinase which is activated following engagement of many different classes of cellular receptors including immune response receptors, integrins and other adhesion receptors, receptor protein tyrosine kinases, G protein-coupled receptors as well as cytokine receptors. Participates in signaling pathways that control a diverse spectrum of biological activities including gene transcription, immune response, cell adhesion, cell cycle progression, apoptosis, migration, and transformation. Due to functional redundancy between members of the SRC kinase family, identification of the specific role of each SRC kinase is very difficult. SRC appears to be one of the primary kinases activated following engagement of receptors and plays a role in the activation of other protein tyrosine kinase (PTK) families. Receptor clustering or dimerization leads to recruitment of SRC to the receptor complexes where it phosphorylates the tyrosine residues within the receptor cytoplasmic domains. Plays an important role in the regulation of cytoskeletal organization through phosphorylation of specific substrates such as AFAP1. Phosphorylation of AFAP1 allows the SRC SH2 domain to bind AFAP1 and to localize to actin filaments. Cytoskeletal reorganization is also controlled through the phosphorylation of cortactin (CTTN) (Probable). When cells adhere via focal adhesions to the extracellular matrix, signals are transmitted by integrins into the cell resulting in tyrosine phosphorylation of a number of focal adhesion proteins, including PTK2/FAK1 and paxillin (PXN) (By similarity). In addition to phosphorylating focal adhesion proteins, SRC is also active at the sites of cell-cell contact adherens junctions and phosphorylates substrates such as beta-catenin (CTNNB1), delta-catenin (CTNND1), and plakoglobin (JUP). Another type of cell-cell junction, the gap junction, is also a target for SRC, which phosphorylates connexin-43 (GJA1). SRC is implicated in regulation of pre-mRNA-processing and phosphorylates RNA-binding proteins such as KHDRBS1 (Probable). Also plays a role in PDGF-mediated tyrosine phosphorylation of both STAT1 and STAT3, leading to increased DNA binding activity of these transcription factors (By similarity). Involved in the RAS pathway through phosphorylation of RASA1 and RASGRF1. Plays a role in EGF-mediated calcium-activated chloride channel activation (By similarity). Required for epidermal growth factor receptor (EGFR) internalization through phosphorylation of clathrin heavy chain (CLTC and CLTCL1) at 'Tyr-1477'. Involved in beta-arrestin (ARRB1 and ARRB2) desensitization through phosphorylation and activation of GRK2, leading to beta-arrestin phosphorylation and internalization. Has a critical role in the stimulation of the CDK20/MAPK3 mitogen-activated protein kinase cascade by epidermal growth factor (Probable). Might be involved not only in mediating the transduction of mitogenic signals at the level of the plasma membrane but also in controlling progression through the cell cycle via interaction with regulatory proteins in the nucleus. Plays an important role in osteoclastic bone resorption in conjunction with PTK2B/PYK2. Both the formation of a SRC-PTK2B/PYK2 complex and SRC kinase activity are necessary for this function. Recruited to activated integrins by PTK2B/PYK2, thereby phosphorylating CBL, which in turn induces the activation and recruitment of phosphatidylinositol 3-kinase to the cell membrane in a signaling pathway that is critical for osteoclast function. Promotes energy production in osteoclasts by activating mitochondrial cytochrome C oxidase (By similarity). Phosphorylates DDR2 on tyrosine residues, thereby promoting its subsequent autophosphorylation (PubMed:16186108). Phosphorylates RUNX3 and COX2 on tyrosine residues, TNK2 on 'Tyr-284' and CBL on 'Tyr-738'. Enhances RIGI-elicited antiviral signaling. Phosphorylates PDPK1 at 'Tyr-9', 'Tyr-373' and 'Tyr-376'. Phosphorylates BCAR1 at 'Tyr-226'. Phosphorylates CBLC at multiple tyrosine residues, phosphorylation at 'Tyr-341' activates CBLC E3 activity. Phosphorylates synaptic vesicle protein synaptophysin (SYP) (PubMed:26026271). Involved in anchorage-independent cell growth (By similarity). Required for podosome formation (By similarity). Mediates IL6 signaling by activating YAP1-NOTCH pathway to induce inflammation-induced epithelial regeneration (By similarity). Phosphorylates OTUB1, promoting deubiquitination of RPTOR (By similarity).
    Show/Hide
Uniprot ID
Primary ID:
Q9WUD9

Secondarily ID:
G3V776
Q45QJ2
Q9JJ10
    Show/Hide
Ensembl ID
ENSG00000197122
Subcellular Location
Cell membrane
Mitochondrion inner membrane
Nucleus
Cytoplasm
Cytoskeleton
Cytoplasm
Perinuclear region
Cell junction
Focal adhesion
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000798 , SR-3Y1-1
Compound ID Compound Name Compound Formula
CP0526688
2-[(Z)-[(4R,6R,8R,9Z,11E)-16-chloro-17,19-dihydroxy-4-methyl-2-oxo-3,7-dioxatricyclo[13.4.0.06,8]nonadeca-1(15),9,11,16,18-pentaen-13-ylidene]amino]oxy-N-[4-(diethylamino)phenyl]acetamide
   Show/Hide
C30H34ClN3O7
 1
1
IC50 < 10 nM
   TI
   LI
   LO
   TS
CP0541992
16-Chloro-17,19-dihydroxy-4-methyl-3,7-dioxa-tricyclo[13.4.0.0*6,8*]nonadeca-1(19),9,11,15,17-pentaene-2,13-dione 13-{O-[2-(4-methyl-piperazin-1-yl)-2-oxo-ethyl]-oxime}
   Show/Hide
C25H30ClN3O7
 1
1
IC50 = 13 nM
   TI
   LI
   LO
   TS
CP0510923
2-(16-Chloro-17,19-dihydroxy-4-methyl-2-oxo-3,7-dioxa-tricyclo[13.4.0.0*6,8*]nonadeca-1(19),9,11,15,17-pentaen-13-ylideneaminooxy)-N-cyclopentyl-acetamide
   Show/Hide
C25H29ClN2O7
 1
1
IC50 = 14 nM
   TI
   LI
   LO
   TS
CP0376262
2-(16-Chloro-17,19-dihydroxy-4-methyl-2-oxo-3,7-dioxa-tricyclo[13.4.0.0*6,8*]nonadeca-1(19),9,11,15,17-pentaen-13-ylideneaminooxy)-N-cyclohexylmethyl-acetamide
   Show/Hide
C27H33ClN2O7
 1
1
IC50 = 17 nM
   TI
   LI
   LO
   TS
CP0453369
16-Chloro-17,19-dihydroxy-4-methyl-3,7-dioxa-tricyclo[13.4.0.0*6,8*]nonadeca-1(19),9,11,15,17-pentaene-2,13-dione 13-[O-(2-oxo-2-piperidin-1-yl-ethyl)-oxime]
   Show/Hide
C25H29ClN2O7
 1
1
IC50 = 25 nM
   TI
   LI
   LO
   TS
CP0505941
2-(16-Chloro-17,19-dihydroxy-4-methyl-2-oxo-3,7-dioxa-tricyclo[13.4.0.0*6,8*]nonadeca-1(19),9,11,15,17-pentaen-13-ylideneaminooxy)-N-phenyl-acetamide
   Show/Hide
C26H25ClN2O7
 1
1
IC50 = 43 nM
   TI
   LI
   LO
   TS
CP0505666
2-(16-Chloro-17,19-dihydroxy-4-methyl-2-oxo-3,7-dioxa-tricyclo[13.4.0.0*6,8*]nonadeca-1(19),9,11,15,17-pentaen-13-ylideneaminooxy)-N-pyridin-3-yl-acetamide
   Show/Hide
C25H24ClN3O7
 1
1
IC50 = 54 nM
   TI
   LI
   LO
   TS
CP0889380
16-Chloro-17,19-dihydroxy-4-methyl-3,7-dioxa-tricyclo[13.4.0.0*6,8*]nonadeca-1(19),9,11,15,17-pentaene-2,13-dione 13-oxime
   Show/Hide
C18H18ClNO6
 1
1
IC50 = 56 nM
   TI
   LI
   LO
   TS
CP0507748
16-Chloro-17,19-dihydroxy-4-methyl-3,7-dioxa-tricyclo[13.4.0.0*6,8*]nonadeca-1(19),9,11,15,17-pentaene-2,13-dione 13-[O-(2-azepan-1-yl-2-oxo-ethyl)-oxime]
   Show/Hide
C26H31ClN2O7
 1
1
IC50 = 67 nM
   TI
   LI
   LO
   TS
CP0431184
16-Chloro-17,19-dihydroxy-4-methyl-3,7-dioxa-tricyclo[13.4.0.0*6,8*]nonadeca-1(19),9,11,15,17-pentaene-2,13-dione 13-[O-(2-oxo-2-pyrrolidin-1-yl-ethyl)-oxime]
   Show/Hide
C24H27ClN2O7
 1
1
IC50 = 70 nM
   TI
   LI
   LO
   TS
CP0522507
16-Chloro-17,19-dihydroxy-4-methyl-3,7-dioxa-tricyclo[13.4.0.0*6,8*]nonadeca-1(19),9,11,15,17-pentaene-2,13-dione 13-[O-(2-morpholin-4-yl-2-oxo-ethyl)-oxime]
   Show/Hide
C24H27ClN2O8
 1
1
IC50 = 140 nM
   TI
   LI
   LO
   TS
CP0068871
Radicicol
   Show/Hide
C18H17ClO6
 1
1
IC50 = 180 nM
   TI
   LI
   LO
   TS
CP0501998
2-(16-Chloro-17,19-dihydroxy-4-methyl-2-oxo-3,7-dioxa-tricyclo[13.4.0.0*6,8*]nonadeca-1(19),9,11,15,17-pentaen-13-ylideneaminooxy)-N-cyclohexyl-acetamide
   Show/Hide
C26H31ClN2O7
 1
1
IC50 = 210 nM
   TI
   LI
   LO
   TS
CP0392326
methyl 2-[[2-[(Z)-[(4R,6R,8R,9Z,11E)-16-chloro-17,19-dihydroxy-4-methyl-2-oxo-3,7-dioxatricyclo[13.4.0.06,8]nonadeca-1(15),9,11,16,18-pentaen-13-ylidene]amino]oxyacetyl]amino]acetate
   Show/Hide
C23H25ClN2O9
 1
1
IC50 = 360 nM
   TI
   LI
   LO
   TS
CP0515026
2-(16-Chloro-17,19-dihydroxy-4-methyl-2-oxo-3,7-dioxa-tricyclo[13.4.0.0*6,8*]nonadeca-1(19),9,11,15,17-pentaen-13-ylideneaminooxy)-N-(4-methoxy-phenyl)-acetamide
   Show/Hide
C27H27ClN2O8
 1
1
IC50 = 390 nM
   TI
   LI
   LO
   TS
CP0401660
2-(16-Chloro-17,19-dihydroxy-4-methyl-2-oxo-3,7-dioxa-tricyclo[13.4.0.0*6,8*]nonadeca-1(19),9,11,15,17-pentaen-13-ylideneaminooxy)-N-(2-hydroxy-ethyl)-acetamide
   Show/Hide
C22H25ClN2O8
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0450262
2-(16-Chloro-17,19-dihydroxy-4-methyl-2-oxo-3,7-dioxa-tricyclo[13.4.0.0*6,8*]nonadeca-1(19),9,11,15,17-pentaen-13-ylideneaminooxy)-N-(2-diethylamino-ethyl)-acetamide
   Show/Hide
C26H34ClN3O7
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0487465
2-(16-Chloro-17,19-dihydroxy-4-methyl-2-oxo-3,7-dioxa-tricyclo[13.4.0.0*6,8*]nonadeca-1(19),9,11,15,17-pentaen-13-ylideneaminooxy)-N-[2-(1-methyl-1H-pyrrol-2-yl)-ethyl]-acetamide
   Show/Hide
C27H30ClN3O7
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0505925
2-(16-Chloro-17,19-dihydroxy-4-methyl-2-oxo-3,7-dioxa-tricyclo[13.4.0.0*6,8*]nonadeca-1(19),9,11,15,17-pentaen-13-ylideneaminooxy)-N,N-bis-(2-hydroxy-ethyl)-acetamide
   Show/Hide
C24H29ClN2O9
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0511080
2-(16-Chloro-17,19-dihydroxy-4-methyl-2-oxo-3,7-dioxa-tricyclo[13.4.0.0*6,8*]nonadeca-1(19),9,11,15,17-pentaen-13-ylideneaminooxy)-N-pyridin-3-ylmethyl-acetamide
   Show/Hide
C26H26ClN3O7
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0520290
2-(16-Chloro-17,19-dihydroxy-4-methyl-2-oxo-3,7-dioxa-tricyclo[13.4.0.0*6,8*]nonadeca-1(19),9,11,15,17-pentaen-13-ylideneaminooxy)-N-(2-ethoxy-ethyl)-acetamide
   Show/Hide
C24H29ClN2O8
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
Similar Protein(s) and Bioactivity Statistics
90% Identity
Protein ID Protein Name Protein Organism
PT00879 Proto-oncogene tyrosine-protein kinase Src Homo sapiens, Human
PT02255 Proto-oncogene tyrosine-protein kinase Src Mus musculus, Mouse
50% Identity
Protein ID Protein Name Protein Organism
PT01066 Tyrosine-protein kinase Yes Homo sapiens, Human
PT01342 Tyrosine-protein kinase Fgr Homo sapiens, Human